Skip to main content
OpenTrials
Completed

NCT Number: NCT01072513

Semen Analysis After Proton Therapy for Prostate Cancer

The purpose of this study is to evaluate semen for changes following treatment with proton radiation therapy.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

University of Florida Proton Therapy Institute

Jacksonville, Florida, 32206, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosis of low to intermediate risk prostate cancer and elected to have proton radiation therapy at University of Florida Proton Therapy Institute (UFPTI).

Exclusion criteria

  • Current use of Flomax, Hytrin, Cardura, Uroxatral, or Rapaflo.
  • History of vasectomy.
  • Current use of Lupron, Zoladex, Trelstar, Casodex, Eulexin.
  • Current use of Avodart or Proscar.

Treatment and study plan

Semen analysis

Other

Semen analysis before and after proton radiation therapy.

Primary outcomes

  1. Post treatment sperm count

    Time frame: 12 months after radiation therapy

Secondary outcomes

  1. Compare changes in sperm motility, sperm morphology and semen PH.

    Time frame: 12 months after radiation therapy

    This is composite measure

Sponsors and collaborators

Lead sponsor

University of Florida

Other

Registry information

Official study title

Semen Analysis Following Definitive Treatment of Prostate Cancer With Proton Radiation Therapy Alone

Acronym: PR08

Important dates

Study start
2010
Primary completion
2014
Study completion
2015
First posted
Feb 22, 2010
Registry last updated
Apr 6, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.